Full-Time

Senior – Scientist

Proteomics

Posted on 4/12/2025

Flagship Pioneering

Flagship Pioneering

201-500 employees

Biotechnology firm creating health and sustainability solutions

No salary listed

Senior

Boston, MA, USA

This is an on-site role in South Boston.

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD or equivalent experience in proteomics with 3 years additional experience, preferably in a drug discovery setting.
  • Demonstrated experience in developing and implementing studies to compare protein expression on cell surfaces and in different tissue types.
  • Demonstrated experience in designing, performing and analyzing mass spectrometry experiments.
  • Demonstrated experience in characterizing epitope accessibility on cell surfaces.
  • Demonstrated experience in cell culture and protein enrichment techniques.
  • Demonstrated experience in analysis, cataloguing, and mining multiomic data in collaboration with data scientists.
  • Excellent written and verbal communication skills and experience presenting results and scientific data to team leaders, cross-functional teams, academic collaborators, or partners.
Responsibilities
  • Design, plan, and execute proteomic studies to support target selection of multi-specific antibodies.
  • Develop tissue assays to assess binding and drug activity patterns of therapeutic antibodies and multi-specific molecules across portfolio projects, particularly in the fields of inflammation and immunology.
  • Collaborate with our Protein Sciences team to optimize the developability profiles of candidate molecules, and with the In Vivo Pharmacology team to evaluate tissue specific PK/PD, efficacy, and toxicity.
  • Collaborate with and oversee research activities conducted by Contract Research Organizations (CROs) and partners.
  • Contribute to preparing and writing INDs for therapeutic candidates.
  • Maintain scientific and technical expertise through familiarity with scientific literature.
  • Contribute to building a positive, team-oriented biotech culture.
Desired Qualifications
  • Enthusiasm for playing a pivotal role in the dynamic and multidisciplinary environment of a small biotech.

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Size

201-500

Company Stage

N/A

Total Funding

$10.5B

Headquarters

Cambridge, Maryland

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Etiome's launch with $50M aims to redefine disease progression detection.
  • Lila Sciences, backed by $200M, automates scientific discovery with AI and robotics.
  • Collaboration with Cambridge University Health Partners accelerates biotech research and innovation.

What critics are saying

  • Increased competition in AI-driven discovery may lead to market saturation.
  • Over-reliance on partnerships could cause strategic misalignments or dependency issues.
  • Rapid technological advancements may challenge Flagship's ability to maintain a competitive edge.

What makes Flagship Pioneering unique

  • Flagship Pioneering creates first-in-category ventures transforming health and sustainability.
  • The company combines innovative capacity with entrepreneurial leadership and capital management.
  • Flagship Pioneering systematically produces pioneering companies through an evolutionary methodology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Flexible Work Hours

Company News

VC News Daily
Apr 25th, 2025
Etiome Launches With $50M

CAMBRIDGE, MA, Etiome has announced a $50 million financing round from Flagship Pioneering.

Venture Capital
Apr 25th, 2025
Flagship Pioneering Unveils Etiome to Redefine Disease Progression Detection

Flagship Pioneering unveils Etiome to redefine disease progression detection.

Health Technology Insights
Apr 24th, 2025
Flagship Pioneering Unveils Etiome to Pioneer Preemptive Healthcare

Flagship Pioneering, the bioplatform innovation company, unveiled Etiome, a company redefining how Health Technology Insights.

GlobeNewswire
Mar 19th, 2025
Ampersand Biomedicines Raises Series B Financing and Highlights Pipeline Advancements

$65 million in Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly & Company Two lead programs in...

BioPharmaTrend
Mar 11th, 2025
Lila Sciences Raises $200M to Automate Scientific Discovery with AI and Robotics

Flagship Pioneering has announced the launch of Lila Sciences, a company developing an AI-based platform designed to automate scientific experimentation and discovery.

INACTIVE